The false-negative rate of AFP screening test may be as high as 40% for early-stage HCC detection.13 Even in patients with advanced-stage HCC, AFP screening test still has 15% to 30% false-negative rate.14 Thus, noninvasive and accurate biomarkers are urgently needed for HCC diagnosis. The gene discussed is AFP; the disease is hepatocellular carcinoma.